These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27354694)

  • 41. Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures.
    Lussier YA; Stadler WM; Chen JL
    J Am Med Inform Assoc; 2012; 19(2):156-60. PubMed ID: 22101905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ncRNAppi--a tool for identifying disease-related miRNA and siRNA targeting pathways.
    Ng KL; Liu HC; Lee SC
    Bioinformatics; 2009 Dec; 25(23):3199-201. PubMed ID: 19808883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.
    Song YZ; Li X; Li W; Wang Z; Li K; Xie FL; Zhang F
    World J Gastroenterol; 2018 Jul; 24(28):3145-3154. PubMed ID: 30065560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlating bladder cancer risk genes with their targeting microRNAs using MMiRNA-Tar.
    Liu Y; Baker S; Jiang H; Stuart G; Bai Y
    Genomics Proteomics Bioinformatics; 2015 Jun; 13(3):177-82. PubMed ID: 26169799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predicting cancer drug response by proteomic profiling.
    Ma Y; Ding Z; Qian Y; Shi X; Castranova V; Harner EJ; Guo L
    Clin Cancer Res; 2006 Aug; 12(15):4583-9. PubMed ID: 16899605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TarPmiR: a new approach for microRNA target site prediction.
    Ding J; Li X; Hu H
    Bioinformatics; 2016 Sep; 32(18):2768-75. PubMed ID: 27207945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes.
    Chen Y; Gao Z; Wang B; Xu R
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):516. PubMed ID: 27557118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug Response Prediction as a Link Prediction Problem.
    Stanfield Z; Coşkun M; Koyutürk M
    Sci Rep; 2017 Jan; 7():40321. PubMed ID: 28067293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types.
    Doecke JD; Wang Y; Baggerly K
    Cancer Genet; 2016 Oct; 209(10):463-473. PubMed ID: 27810075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway Model.
    Fröhlich F; Kessler T; Weindl D; Shadrin A; Schmiester L; Hache H; Muradyan A; Schütte M; Lim JH; Heinig M; Theis FJ; Lehrach H; Wierling C; Lange B; Hasenauer J
    Cell Syst; 2018 Dec; 7(6):567-579.e6. PubMed ID: 30503647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas Data.
    Mamatjan Y; Agnihotri S; Goldenberg A; Tonge P; Mansouri S; Zadeh G; Aldape K
    J Mol Diagn; 2017 Nov; 19(6):881-891. PubMed ID: 28867603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ensemble Methods for MiRNA Target Prediction from Expression Data.
    Le TD; Zhang J; Liu L; Li J
    PLoS One; 2015; 10(6):e0131627. PubMed ID: 26114448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene signature-based prediction of tumor response to cyclophosphamide.
    Korrat A; Greiner T; Maurer M; Metz T; Fiebig HH
    Cancer Genomics Proteomics; 2007; 4(3):187-95. PubMed ID: 17878522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
    Yang J; Zeng Y
    Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting Cancer Drug Response using a Recommender System.
    Suphavilai C; Bertrand D; Nagarajan N
    Bioinformatics; 2018 Nov; 34(22):3907-3914. PubMed ID: 29868820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.
    Liang L; Wei DM; Li JJ; Luo DZ; Chen G; Dang YW; Cai XY
    Mol Med Rep; 2018 Jan; 17(1):939-951. PubMed ID: 29115476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational models for predicting drug responses in cancer research.
    Azuaje F
    Brief Bioinform; 2017 Sep; 18(5):820-829. PubMed ID: 27444372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel.
    Cortés-Ciriano I; van Westen GJ; Bouvier G; Nilges M; Overington JP; Bender A; Malliavin TE
    Bioinformatics; 2016 Jan; 32(1):85-95. PubMed ID: 26351271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using Transcriptional Signatures to Find Cancer Drivers with LURE.
    Haan D; Tao R; Friedl V; Anastopoulos IN; Wong CK; Weinstein AS; Stuart JM
    Pac Symp Biocomput; 2020; 25():343-354. PubMed ID: 31797609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.